Bristol-Myers Squibb Company
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
Last updated:
Abstract:
The present invention provides a compound of formula (II): an inhibitor of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. Its prodrugs are disclosed. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
3 Jan 2019
Issue date:
11 Mar 2021